From: Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization
Grade change (N = 142)
EZ-ALBI, N (%)
ALBI, N (%)
Improving grade
6 (4.2%)
Same grade
94 (66.2%)
92 (64.8%)
Worsening grade
42 (29.6%)
44 (31.0%)